ROBO Global Healthcare Technology and Innovation ETF

HTEC

Market cap $74.1M

Portfolios are commonly underexposed to the companies driving healthcare innovation. As technological disruptions build across medical fields, the ROBO Global Healthcare Technology and Innovation ETF (HTEC) provides targeted exposure to the global value chain driving this high-growth opportunity.

Station on Tsawwassen First Nation land in British Columbia marks a key milestone for the deployment of hydrogen-powered trucks Station on Tsawwassen First Nation land in British Columbia marks a key milestone for the deployment of hydrogen-powered trucks

Investors once shrugged off industrials as slow-growth cyclical businesses that lagged tech at every turn. But the AI boom has driven a significant re-rating of the sector.

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

The healthcare sector is undergoing a profound transformation, driven by rapid technological advancements and shifting global demographics. The leaders of this transformation go far beyond the big pharmaceutical names that dominate healthcare strategies.

The 2026 Brown Brothers Harriman (BBH) Global ETF Investor Survey revealed a constant data point — demand for ETFs remains robust on a global scale. However, the current market environment is shifting the tide, giving way to specific trends in an ETF marketplace that continues to evolve.

TMX VettaFi writers Ben Hernandez and DJ Shaw delved into the world of crypto ETFs in the last Bull vs. Bear. In this edition, writers Nick Peters-Golden and Elle Fitzgerald focus on artificial intelligence — specifically, AI ETFs.

The artificial intelligence and robotics investment opportunity extends far beyond the headline-grabbing tech giants, offering exposure to a diverse ecosystem of enablers and application developers that many investors overlook, according to experts at VettaFi's Winter Symposium on Thursday.

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.